Alessandra Vergori to Reverse Transcriptase Inhibitors
This is a "connection" page, showing publications Alessandra Vergori has written about Reverse Transcriptase Inhibitors.
Connection Strength
0.212
-
Prevalence of predicted resistance to doravirine in HIV-1-positive patients after exposure to non-nucleoside reverse transcriptase inhibitors. Int J Antimicrob Agents. 2019 Apr; 53(4):515-519.
Score: 0.166
-
COVID-19 in people living with HIV: Clinical implications of dynamics of the immune response to SARS-CoV-2. J Med Virol. 2021 03; 93(3):1796-1804.
Score: 0.046